Home NDC 0049-0352 Geodon
Product NDC 0049-0352
11-digit product format 000490352
Labeler code 0049
Product ID 0049-0352_47ba0a29-e695-4b74-b0c4-8510214c9057
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ziprasidone
Dosage form CAPSULE
Route ORAL
Labeler ROERIG
Application NDA020825
Marketing category NDA
Marketing start 2021-11-08
Substance ZIPRASIDONE
Active strength 20 mg/1
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020825-001 GEODON ZIPRASIDONE HYDROCHLORIDE EQ 20MG BASE CAPSULE / ORAL AB RLD, RS 2001-02-05 N020825-002 GEODON ZIPRASIDONE HYDROCHLORIDE EQ 40MG BASE CAPSULE / ORAL AB RLD 2001-02-05 N020825-003 GEODON ZIPRASIDONE HYDROCHLORIDE EQ 60MG BASE CAPSULE / ORAL AB RLD 2001-02-05 N020825-004 GEODON ZIPRASIDONE HYDROCHLORIDE EQ 80MG BASE CAPSULE / ORAL AB RLD 2001-02-05
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 176 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N020825-001 GEODON EQ 20MG BASE CAPSULE / ORAL AB RLD, RS 2001-02-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020825-002 GEODON EQ 40MG BASE CAPSULE / ORAL AB RLD 2001-02-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020825-003 GEODON EQ 60MG BASE CAPSULE / ORAL AB RLD 2001-02-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020825-004 GEODON EQ 80MG BASE CAPSULE / ORAL AB RLD 2001-02-05 c2088c7a36db…2026-09-14 22:38:34 2026-08 N020825-001 GEODON EQ 20MG BASE CAPSULE / ORAL AB RLD, RS 2001-02-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020825-002 GEODON EQ 40MG BASE CAPSULE / ORAL AB RLD 2001-02-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020825-003 GEODON EQ 60MG BASE CAPSULE / ORAL AB RLD 2001-02-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020825-004 GEODON EQ 80MG BASE CAPSULE / ORAL AB RLD 2001-02-05 84e616aacf4f…2026-08-18 06:07:40 2026-07 N020825-001 GEODON EQ 20MG BASE CAPSULE / ORAL AB RLD, RS 2001-02-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020825-002 GEODON EQ 40MG BASE CAPSULE / ORAL AB RLD 2001-02-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020825-003 GEODON EQ 60MG BASE CAPSULE / ORAL AB RLD 2001-02-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020825-004 GEODON EQ 80MG BASE CAPSULE / ORAL AB RLD 2001-02-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020825-001 GEODON EQ 20MG BASE CAPSULE / ORAL AB RLD, RS 2001-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020825-002 GEODON EQ 40MG BASE CAPSULE / ORAL AB RLD 2001-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020825-003 GEODON EQ 60MG BASE CAPSULE / ORAL AB RLD 2001-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020825-004 GEODON EQ 80MG BASE CAPSULE / ORAL AB RLD 2001-02-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020825-001 GEODON EQ 20MG BASE CAPSULE / ORAL AB RLD, RS 2001-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020825-002 GEODON EQ 40MG BASE CAPSULE / ORAL AB RLD 2001-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020825-003 GEODON EQ 60MG BASE CAPSULE / ORAL AB RLD 2001-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020825-004 GEODON EQ 80MG BASE CAPSULE / ORAL AB RLD 2001-02-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020825-001 GEODON EQ 20MG BASE CAPSULE / ORAL AB RLD, RS 2001-02-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020825-002 GEODON EQ 40MG BASE CAPSULE / ORAL AB RLD 2001-02-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020825-003 GEODON EQ 60MG BASE CAPSULE / ORAL AB RLD 2001-02-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020825-004 GEODON EQ 80MG BASE CAPSULE / ORAL AB RLD 2001-02-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020825-001 GEODON EQ 20MG BASE CAPSULE / ORAL AB RLD, RS 2001-02-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020825-002 GEODON EQ 40MG BASE CAPSULE / ORAL AB RLD 2001-02-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020825-003 GEODON EQ 60MG BASE CAPSULE / ORAL AB RLD 2001-02-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020825-004 GEODON EQ 80MG BASE CAPSULE / ORAL AB RLD 2001-02-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020825-001 GEODON EQ 20MG BASE CAPSULE / ORAL AB RLD, RS 2001-02-05 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020825-002 GEODON EQ 40MG BASE CAPSULE / ORAL AB RLD 2001-02-05 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020825-003 GEODON EQ 60MG BASE CAPSULE / ORAL AB RLD 2001-02-05 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020825-004 GEODON EQ 80MG BASE CAPSULE / ORAL AB RLD 2001-02-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020825-001 GEODON EQ 20MG BASE CAPSULE / ORAL AB RLD, RS 2001-02-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020825-002 GEODON EQ 40MG BASE CAPSULE / ORAL AB RLD 2001-02-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020825-003 GEODON EQ 60MG BASE CAPSULE / ORAL AB RLD 2001-02-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020825-004 GEODON EQ 80MG BASE CAPSULE / ORAL AB RLD 2001-02-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020825-001 GEODON EQ 20MG BASE CAPSULE / ORAL AB RLD, RS 2001-02-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020825-002 GEODON EQ 40MG BASE CAPSULE / ORAL AB RLD 2001-02-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020825-003 GEODON EQ 60MG BASE CAPSULE / ORAL AB RLD 2001-02-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020825-004 GEODON EQ 80MG BASE CAPSULE / ORAL AB RLD 2001-02-05 2680178bc6a6…
Observed Orange Book normalized TE history# Normalized TE history page 5 of 5 · 176 observed states.
Observed Orange Book patent history# Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 116 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Geodon
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ZIPRASIDONE 20 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0049-0352-60 Geodon 60 in 1 BOTTLE CAPSULE 60 48
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ZIPRASIDONE HYDROCHLORIDE ACTIVE INGREDIENT 216X081ORU GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 ZIPRASIDONE MESYLATE ACTIVE INGREDIENT 3X6SAX83JZ GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 ZIPRASIDONE ACTIVE MOIETY 6UKA5VEJ6X GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 LACTOSE INACTIVE INGREDIENT J2B2A4N98G GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 METHANESULFONIC ACID INACTIVE INGREDIENT 12EH9M7279 GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27 SULFOBUTYLETHER .BETA.-CYCLODEXTRIN INACTIVE INGREDIENT 2PP9364507 GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ROERIG] 27
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0049-0352 GEODON (ZIPRASIDONE HYDROCHLORIDE) CAPSULE GEODON (ZIPRASIDONE MESYLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION GEODON (ZIPRASIDONE) CAPSULE [ROERIG] 46 Current NDC, Legacy NDC, 1 package rows 20250129_8326928a-2cb6-4f7f-9712-03a425a14c37.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0049-0352-60 00049035260 60 CAPSULE in 1 BOTTLE (0049-0352-60) 60 capsule 2021-11-08 0000-00-00 No No Current